Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

STRATA Skin Sciences (SSKN) Income from Continuing Operations (2016 - 2025)

STRATA Skin Sciences' Income from Continuing Operations history spans 14 years, with the latest figure at 3458000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 173.19% to 3458000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 2861000.0, a 74.27% increase, with the full-year FY2025 number at 6212000.0, up 38.41% from a year prior.
  • Income from Continuing Operations hit 3458000.0 in Q4 2025 for STRATA Skin Sciences, up from 1622000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for SSKN hit a ceiling of 3458000.0 in Q4 2025 and a floor of 4725000.0 in Q4 2024.
  • Historically, Income from Continuing Operations has averaged 1610450.0 across 5 years, with a median of 1983000.0 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: crashed 3138.33% in 2023 and later skyrocketed 173.19% in 2025.
  • Tracing SSKN's Income from Continuing Operations over 5 years: stood at 849000.0 in 2021, then surged by 85.87% to 120000.0 in 2022, then crashed by 3138.33% to 3886000.0 in 2023, then decreased by 21.59% to 4725000.0 in 2024, then surged by 173.19% to 3458000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for SSKN at 3458000.0 in Q4 2025, 1622000.0 in Q3 2025, and 2575000.0 in Q2 2025.